Patent · US Active

C3 exoenzyme-coated stents and uses thereof for treating and preventing restenosis

US7662178B2 · kind B2 · utility

4Cited by

21References

64Claims

0Family size

Assignee

The Trustees of Columbia University in the City of New York · US

Inventors

Steven Marx · New York, US
Andrew Marks · Larchmont, US

Key dates

Filing date	Apr 29, 2008
Grant date	Feb 16, 2010
Priority date	—
Expiry date	Jul 25, 2028

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61F2250/0067
WIPO fieldMedical technology
WIPO sectorInstruments

Abstract

This invention provides a stent for implantation in a blood vessel or other tissue, wherein the stent is coated with or contains C3 exoenzyme, a chimeric version thereof or an inhibitor of RhoA. This invention also provides a method for treating or inhibiting the onset of restenosis in a subject which comprises implanting one of the instant stents in the subject's blood vessel.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.